Friday night, Vice Chancellor Parsons wrote his opinion in the on-going legal dispute between PharmAthene (NYSEMKT:PIP) and SIGA Technologies (NASDAQ:SIGA). Parsons issued two documents: a 55-page memo describing his remedy for SIGA's breach of its contractual obligation to negotiate in good faith and a much shorter implementing order that provided the details for how the award was to be calculated.
In 2011, he imposed an income stream remedy, but SIGA appealed. Last May, the Supreme Court upheld his finding that SIGA had breached its contractual obligation, but remanded the remedy. There were several issues, including that the remedy needed to be based on contract law, and that the remedy needed to be based upon the two...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|